Iron Metabolism in the Recovery Phase of Critical Illness with a Focus on Sepsis.
Xiyang ZhangBruce HolbeinJuan ZhouChristian LehmannPublished in: International journal of molecular sciences (2024)
Iron is an essential nutrient for humans and microbes, such as bacteria. Iron deficiency commonly occurs in critically ill patients, but supplementary iron therapy is not considered during the acute phase of critical illness since it increases iron availability for invading microbes and oxidative stress. However, persistent iron deficiency in the recovery phase is harmful and has potential adverse outcomes such as cognitive dysfunction, fatigue, and cardiopulmonary dysfunction. Therefore, it is important to treat iron deficiency quickly and efficiently. This article reviews current knowledge about iron-related biomarkers in critical illness with a focus on patients with sepsis, and provides possible criteria to guide decision-making for iron supplementation in the recovery phase of those patients.
Keyphrases
- iron deficiency
- oxidative stress
- intensive care unit
- decision making
- end stage renal disease
- acute kidney injury
- healthcare
- chronic kidney disease
- stem cells
- dna damage
- physical activity
- systematic review
- prognostic factors
- bone marrow
- mesenchymal stem cells
- patient reported outcomes
- replacement therapy
- heat shock protein
- patient reported